... , S.D. (2008), “ Recognizing consumer issues in DTC pharmaceutical advertising ”, The Journal of Consumer Affairs , Vol. 42 , Spring , pp. 60 ‐ 80 . © Emerald Group Publishing Limited 2009 Pharmaceuticals industry Advertising Consumer marketing Medical products The most...

.... Pharmaceuticals industry Consumer psychology Marketing strategy Internet © Emerald Group Publishing Limited 2005 Finally, in the third stage of the research project, the sites on 300 online pharmacies were accessed, and the main marketing procedures used by online pharmacies were identified...

...Greg Finlayson; Ross Mullner Purpose The purpose of this paper is to review the issues regarding direct‐to‐consumer advertising that have been identified in the literature from the perspective of consumers, consumer groups, physicians, the medical profession and the pharmaceutical industry...

... of promotional activities within the marketing mix, advertising is likely the most visible and noticeable component (Coulter et al., 2001). This is clearly exemplified in the pharmaceutical industry where expenditures on promotions have grown from $2.64 billion in 2002 to $3.2 billion in 2003 (Slaughter...

... are the experts, or so we like to believe. And with the medical doctors as the decision makers, for many years the pharmaceutical industry exclusively focused their brand‐name promotional practices on physicians. Even with the more recent advent of direct‐to‐consumer (DTC) advertising, the companies' sales...

... limitations/implications This is a descriptive framework that has not been validated for its use in the pharmaceutical market. Practical implications Offers a useful framework for academics, managers, students, and individuals to classify and study developments in the pharmaceutical industry...

... positioning in the value‐added chain. In order to fill this knowledge gap, this paper attempts to answer the following research objectives: © Emerald Group Publishing Limited 2004 Small to medium‐sized enterprises Market position Value added Value chain Pharmaceuticals industry United...

...Herbert Jack Rotfeld Looks at the use of brand names in the pharmaceutical industry in comparison with generic versions. Gives a brief history of brand name development. Concludes that brand names for pharmaceutical drugs should be banned since this is open to abuse in the area of cost enhancement...